TOP STORIES

• BUSINESS Filgrastim Biosimilars: Overseas Track Record vs. “Purely Made-in-Japan” Label
  June 25, 2013

• ACADEMIA Makers Should Venture into Drug Development Using iPS, CiRA Adviser Asonuma Says
  June 25, 2013

• REGULATORY FPMAJ May Find it Difficult to Compile Unified Statement of Views on TPP Talks Due to Disagreement among Original and Generic Drug Makers
  June 24, 2013

• ORGANIZATION JGA Concerned about TPP Talks, Hopes Japan Will Adopt US Rules Favorable to Generic Makers
  June 24, 2013

• ORGANIZATION JPMA Weighs Scheme to Allow Use of Clinical Research Evidence for Drug Applications
  June 21, 2013

• BUSINESS Anatomy of Mutual Reliance - Diovan Papers and Company Part 2: Explanations to the World Urged
  June 21, 2013

• REGULATORY MHLW to Resume Inviting Requests for Development of Unapproved Drugs, Indications; No Deadline Set This Time
  June 20, 2013

• BUSINESS Anatomy of Mutual Reliance - Diovan Papers and Company Part 1: A Blurred Line
  June 20, 2013

• BUSINESS Novartis Pharma to Voluntarily Refrain from Participation in JPMA’s Board of Directors Meeting
  June 19, 2013

• REGULATORY MHLW to Temporarily Withdraw Recommendation of Preventive Cervical Cancer Vaccinations
  June 18, 2013

• REGULATORY Cabinet Approves PM Abe’s Growth Strategy, Regulatory Reform Plan
  June 17, 2013

• BUSINESS ARBs Still Best Sellers in FY2012 Sales Ranking, Januvia Ranks in Top 10 after only 3 Years of Launch
  June 14, 2013

• REGULATORY CSIMC’s Expert Subcommittee on NHI Drug Pricing Affairs to Hold Hearings for Drug Pricing Organization at Next Meeting in July
  June 14, 2013

• REGULATORY CSIMC Expert Subcommittee: Reps Agree on Need to Redress Price Variations of Generics
  June 13, 2013

• BUSINESS 6 Antipsychotics in PIII Studies; Flurry of NDA Filings Expected in 2015
  June 12, 2013

• REGULATORY Expert Subcommittee to Begin Discussions on Next Year’s NHI Price Revision on June 12
  June 11, 2013

• ORGANIZATION 30% of Newly Listed Drugs in FY2012 Developed at Request of Govt: FPMAJ Survey
  June 10, 2013

• REGULATORY Japan Set to Perk Up R&D to Expand Drug Market to 9 Trillion Yen in 2020
  June 7, 2013

• BUSINESS Nichi-Iko Announces Launching of Authorized Generic of Allegra in June; Is Late Launch Part of Sanofi’s Carefully Worked-out Strategy?
  June 7, 2013

• ACADEMIA Clinical Pharmacology Network to Go Into Operation with 8 Institutions
  June 6, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 217
• 218
• 219
• 220
• 221
• 222
• 223
• 224
• 225
• …
• Next ›
• 最終 »